Targeting the BCL-2 family in malignancies of germinal centre origin

Author： Spender Lindsay C Inman Gareth J

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.12, 2009-12, pp. : 1459-1472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu Quinn Bridget A Das Swadesh K Dash Rupesh Emdad Luni Dasgupta Santanu Wang Xiang-Yang Dent Paul Reed John C Pellecchia Maurizio Sarkar Devanand Fisher Paul B

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Targeting Bcl-2 in CLL

Current Medicinal Chemistry, Vol. 19, Iss. 30, 2012-10 ,pp. : 5109-5115

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RSK2 in human malignancies

By Kang Sumin Chen Jing

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2964-2978

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2051-2060

Bentham Science Publishers

Access to resources Recommend Favorite